Medical Unitersity Graz, Department of Radiology, Division of General Radiology
Graz, Styria, 8036, Austria
NCT Number: NCT01725763
Pulmonary hypertension (PH) is a life-threatening cardiovascular disease characterized by pathological elevation of mean pulmonary arterial pressure (mPAP) >/= 25 mmHg at rest. mPAP < 20 mmHg is defined as normal, values in the range between 21-24 mmHg are described as "borderline PH" diagnosed by right heart catheterization. Based on the etiology, PH is assigned to 5 groups (WHO, Data Point, 2008), whereas classification of disease is an important prognostic and therapy-deciding criterion.
Cardiac magnetic resonance tomography (CMR) provides a reliable technique to estimate elevated mean pulmonary arterial pressure from period of existence of a vortical motion of blood flow in the main pulmonary artery. Vortex can be visualized in 3-dimensional vector field, particle trace and streamline representations and can be analysed with respect to vortex related measures (geometry of center, vortex formation, vorticity, propagation dynamics …). Furthermore T1-mapping and non-contrast enhanced lung perfusion/ventilation scans represent promising techniques for PH characterization.
Aim of this explorative study is to 1. analyse PH-associated blood flow characteristics in the heart and the surrounding great vessels with respect to the 5 groups of PH, and 2. investigate the hemodynamic state of "borderline PH" compared to normal mPAP and manifest PH by non-contrast CMR.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Graz, Styria, 8036, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
fluid dynamical properties of blood flow patterns in the heart and surrounding great vessels associated with ethiology of PH
Time frame: 2 years
left and right ventricular myocardial T1 times associated with ethiology of PH
Time frame: 2 years
pulmonary ventilation and perfusion associated with ethiology of PH
Medical University of Graz
Other
Acronym: CMR-PH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07445347
Bevacizumab, Cardiovascular Abnormalities
Poitiers, France
View Trial DetailsNCT03683186
Cardiovascular Diseases, Connective Tissue Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06931886
Cardiovascular Diseases, Hypertension
Tucson, Arizona, United States
View Trial DetailsNCT01571700
Cardiovascular Diseases, Hypertension
Stanford, California, United States
View Trial Details